Accuracy of the SEVEN® Continuous Glucose Monitoring System: Comparison with Frequently Sampled Venous Glucose Measurements

Background: The purpose of this study was to compare the accuracy of measurements obtained from the DexCom™ SEVEN® system with Yellow Springs Instrument (YSI) laboratory measurements of venous blood glucose. Methods: Seventy-two subjects with insulin-requiring diabetes, aged 18–71, were enrolled in a multicenter, prospective single-arm study. All participants wore the SEVEN continuous glucose monitoring (CGM) system for one, 7-day wear period. Calibration with capillary finger stick measurements was performed 2 hours after sensor insertion and once every 12 hours thereafter. A subset of subjects (28) wore two systems simultaneously to assess precision. All subjects participated in one, 10-hour in-clinic session on day 1, 4, or 7 of the study to compare CGM measurements against a laboratory method (YSI analyzer) using venous measurements taken once every 20 minutes. Carbohydrate consumption and insulin dosing were adjusted in order to obtain a broad range of glucose values. Results: Comparison of CGM measurements with the laboratory reference method (n = 2318) gave mean and median absolute relative differences (ARDs) of 16.7 and 13.2%, respectively. The percentage was 70.4% in the clinically accurate Clarke error grid A zone and 27.5% in the benign error B zone. Performance of the SEVEN system was consistent over time with mean and median ARD lowest on day 7 as compared to YSI (13.3 and 10.2%, respectively). Average sensor time lag was 5 minutes. Conclusions: Measurements of the DexCom SEVEN system were found to be consistent and accurate compared with venous measurements made using a laboratory reference method over 7 days of wear.

[1]  Roy W Beck,et al.  Variation of Interstitial Glucose Measurements Assessed by Continuous Glucose Monitors in Healthy, Nondiabetic Individuals , 2010, Diabetes Care.

[2]  S. Garg,et al.  Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems. , 2009, Diabetes technology & therapeutics.

[3]  F. Ovalle,et al.  Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes , 2009 .

[4]  Michael O'Grady,et al.  Continuous glucose monitoring and intensive treatment of type 1 diabetes. , 2008, The New England journal of medicine.

[5]  Howard C. Zisser,et al.  Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. , 2007, Diabetes technology & therapeutics.

[6]  R. Brazg,et al.  Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System , 2007, Diabetes Care.

[7]  L. Jovanovic,et al.  Relationship of Fasting and Hourly Blood Glucose Levels to HbA1c Values , 2006, Diabetes Care.

[8]  Jean-Paul Cristol,et al.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.

[9]  Michael Brownlee,et al.  Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. , 2006, JAMA.

[10]  R. Hovorka Continuous glucose monitoring and closed‐loop systems , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[11]  Howard Zisser,et al.  Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. , 2006, Diabetes care.

[12]  B. Zinman,et al.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.

[13]  Continuous glucose monitoring. , 2005, Diabetes self-management.

[14]  D. Klonoff Continuous glucose monitoring: roadmap for 21st century diabetes therapy. , 2005, Diabetes care.

[15]  I. Hirsch,et al.  Should minimal blood glucose variability become the gold standard of glycemic control? , 2005, Journal of diabetes and its complications.

[16]  Claresa Levetan,et al.  Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. , 2004, Mayo Clinic proceedings.

[17]  D. Cox,et al.  Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. , 2004, Diabetes care.

[18]  C. Chia,et al.  Glucose sensors: toward closed loop insulin delivery. , 2004, Endocrinology and metabolism clinics of North America.

[19]  P. Schaepelynck-Belicar,et al.  Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS). , 2003, Diabetes & metabolism.

[20]  Johnny Ludvigsson,et al.  Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. , 2003, Pediatrics.

[21]  H. Chase,et al.  Use of the GlucoWatch biographer in children with type 1 diabetes. , 2003, Pediatrics.

[22]  The accuracy of the CGMS in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. , 2003, Diabetes technology & therapeutics.

[23]  John M. Lachin,et al.  Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. , 2003, JAMA.

[24]  R. Schiaffini,et al.  The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk , 2002, Diabetes/metabolism research and reviews.

[25]  H. Chase,et al.  Continuous subcutaneous glucose monitoring in children with type 1 diabetes. , 2001, Pediatrics.

[26]  J. Skyler The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system. , 2000, Diabetes technology & therapeutics.

[27]  J. Mastrototaro,et al.  Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. , 1999, Diabetes research and clinical practice.

[28]  The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial , 1995, Diabetes.

[29]  D. Cox,et al.  Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose , 1987, Diabetes Care.

[30]  J. Pennebaker,et al.  Accuracy of Perceiving Blood Glucose in IDDM , 1985, Diabetes Care.

[31]  L. Guttman,et al.  Statistical Adjustment of Data , 1944 .